Association of Patient and Tumor Characteristics With Outcomes in Young Head and Neck Squamous Cell Carcinoma Patients
Ronan W. Hsieh(UPMC Hillman Cancer Center), Dan P. Zandberg(University of Pittsburgh Medical Center), William E. Gooding(UPMC Hillman Cancer Center), José P. Zevallos(University of Pittsburgh Medical Center), Umamaheswar Duvvuri(City University of New York), Uzoma K. Iheagwara(UPMC Health System), Shaum Sridharan(University of Pittsburgh), Marci L. Nilsen(University of Pittsburgh), Robert L. Ferris(University of Pittsburgh), Seungwon Kim(UPMC Hillman Cancer Center), Zahra Kelly(University of Pittsburgh Medical Center), Mark Kubik(University of Pittsburgh), Heath D. Skinner(University of Pittsburgh)
Cited by 4
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma
|JAMA Oncology|2016|1.4k
Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression
|Oral Oncology|2018|802
Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer
|Immunity|2020|688